Monday 6 July, 2026
At MWC Barcelona 2025, Omniscope joined the GSMA Foundry Innovation Showcase at the GSMA Pavilion to demonstrate how AI, sequencing technology and predictive biology are transforming healthcare and personalised medicine.
In this interview filmed at the Pavilion, Vijay Vaswani, CEO and Co-founder of OmniScope, explains how the company has developed high-resolution sequencing technology capable of reading millions of individual immune cells to build one of the world’s first foundational AI models of the immune system.
The discussion explores how OmniScope’s technology is being applied across elite sports and healthcare, from helping athletes optimise recovery and reduce injury risk to launching one of the EU’s largest cancer immunome projects in partnership with the Catalan Institute of Oncology.
“We’re building models of the immune system so that technology can support truly personalised medicine.”
Vijay Vaswani – CEO and Co-founder, OmniScope
